Stockreport

Lexeo Therapeutics (LXEO) Gets a PT Cut to $13 by H.C. Wainwright Due to Equity Raise [Yahoo! Finance]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF Wainwright lowered the firm's price target on Lexeo Therapeutics to $13 from $15 and kept a Buy rating on the shares. The price cut was made as the firm pointed out the [Read more]